Empty Capsules Market Worth $4.47 Billion by 2029

Empty Capsules Market by Type (Gelatin Capsule [Bovine, Porcine], Non-gelatin [HPMC, Pullulan]), Functionality (Sustained-release, Immediate-release, Delayed-release), Application (Antibiotics, Antacids, Anti-inflammatory, Cough), and End User—Global Forecast to 2029.

Meticulous Research^®—leading global market research company published a research report titled, ‘Empty Capsules Market by Type (Gelatin Capsule [Bovine, Porcine], Non-gelatin [HPMC, Pullulan]), Functionality (Sustained-release, Immediate-release, Delayed-release), Application (Antibiotics, Antacids, Anti-inflammatory, Cough), and End User—Forecast to 2029.’

According to this latest publication from Meticulous Research^®, the empty capsules market is expected to grow at a CAGR of 6.7% to reach $4.47 billion by 2029. The growing demand for nutraceuticals and high preference for capsules are the factors driving the growth of this market.

Empty Capsules Market: Future Outlook

The empty capsules market is segmented based on Product Type (Gelatin Capsule [Bovine Gelatin Capsule, Porcine Gelatin Capsule, and Other Gelatin Capsule] and Non-Gelatin Capsule [Hydroxypropyl Methylcellulose {HPMC}, Pullulan & Starch Material], Functionality (Immediate-release Capsules, Sustained-release Capsules, and Delayed-release Capsules), Application (Antibiotic & Antibacterial Drugs, Antacids & Anti-flatulent Preparations, Antianemic Preparations, Anti-inflammatory Drugs, Cardiovascular Therapy Drugs, Cough & Cold Drug Preparations, Dietary Supplements, and Other Applications), End User (Pharmaceutical Companies, Neutraceutical Companies, Cosmetic Industries, and Research Laboratories), and Geography. The study also evaluates industry competitors and analyzes the market at the country level.

Based on product type, in 2022, the gelatin segment is expected to account for the largest share of the market. Gelatin capsules offer advantages such as easy digestion, ease of swallowing, rapid drug release, and uniform mixing of drugs, making them the most favored alternative for capsule manufacturing.

Based on functionality, in 2022, the empty capsules market is segmented into immediate-release capsules, sustained-release capsules, and delayed-release capsules. The immediate-release capsules segment is expected to account for the largest share of the market. The preference for immediate-release capsules for manufacturing antacids, antibacterials, antibiotics, dietary supplements, and cold & cough drug preparations and the advantages offered by the immediate-release capsules, such as rapid dissolution and drug absorption, are the key factors for the large market share of this segment.

Based on application, the empty capsules market is segmented into antibiotic & antibacterial drugs, antacids & anti-flatulent preparations, antianemic preparations, anti-inflammatory drugs, cardiovascular therapy drugs, cough & cold drug preparations, dietary supplements, and other applications. In 2022, the antibiotic & antibacterial drugs segment is expected to account for the largest share of the empty capsules market. The increasing prevalence of infectious diseases and high use of antibacterials to fight common infections are the key factors attributing to the largest share of the market

Based on end user, in 2022, the pharmaceutical companies segment is expected to account for the largest share of the empty capsules market. The large market share of this segment is attributed to the product approvals and new product launches of pharmaceuticals in the capsule dosage form and the increasing production of pharmaceuticals.

This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Rest of Latin America) and Middle East & Africa. North America is expected to account for the largest share of the empty capsules market in 2022, followed by Europe and Asia-Pacific. In 2022, the U.S. is expected to be the largest shareholding market in North America. The large market share is attributed to the presence of large pharmaceutical companies with huge capsule production capabilities.

The key players operating in the empty capsules market are ACG Worldwide (India), Capsugel (U.S.), CapsCanada Corporation (Canada), Qingdao Yiqing Medicinal Capsules Co., Ltd. (China), Healthcaps India Ltd. (India), NATURAL CAPSULES LIMITED (India), Goerlich Pharma GmbH (Germany), Qualicaps (US), Bright Pharma Caps Inc. (U.S.), Suheung Co. Ltd. (South Korea), and Roxlor LLC (U.S.).

Download Sample Copy Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5344

Key questions answered in the report-

Which are the high-growth market segments in terms of product type, functionality, application, end user, and region/country?
What was the historical market for empty capsules across the globe?
What are the market forecasts and estimates for the period 2022–2029?
What are the major drivers, restraints, challenges, and opportunities in the global market of empty capsules?
Who are the major players in the empty capsules market?
How is the competitive landscape, and who are the market leaders in the empty capsules market?
What are the recent developments in the empty capsules market?
What are the different strategies adopted by the major players in the empty capsules market?
What are the geographical trends and high growth regions/countries?

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research